Pfizer and Moderna vaccines proved very effective against COVID Omicron variant, study shows
The two main COVID-19 vaccines used in the U.S., Pfizer-BioNTech's and Moderna's, remained highly effective at preventing hospitalization and death from the Omicron variant, even if they were less effective at preventing mild infections, a report released Friday by the Centers for Disease Control and Prevention shows. And people who got a third dose fared best.
Two doses of the vaccines were 79 percent effective at preventing people from dying or going on ventilators during the Omicron surge, the tracking report found, while those who got a booster shot ended up with 94 percent protection. "Anybody who is skeptical really needs to look at that number and think, 'Okay, maybe I'm going to get a cold and feel sick, but ... I'm not going to get put on a ventilator or die,'" Jeanne Marrazzo, director of the Division of Infectious Diseases at the University of Alabama at Birmingham, tells The Washington Post.
The CDC study looked at COVID-19 cases at 21 hospitals in 18 states from March 11, 2021, to Jan. 24, giving researchers a view of how vaccines worked against the Alpha, Delta, and Omicron variants. William Schaffner, an infectious-disease specialist at Vanderbilt University Medical Center, called the report "solid gold." "This is such solid information that reinforces the current recommendation to get vaccinated and boosted — and [the vaccine] worked for Omicron," he told the Post.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
As Omicron has waned, COVID-19 cases have fallen dramatically in the U.S. But a new subvariant, BA.2, is causing a massive wave of infections in China and a more modest rise in infections in Europe, and it is overtaking Omicron in the U.S., too. "Whether or not that is going to lead to another surge, a mini surge or maybe even a moderate surge, is very unclear because there are a lot of other things that are going on right now," Dr. Antony Fauci, President Biden's medical adviser, tells an ABC News podcast.
The BA.2 subvariant is similar to original Omicron, though even more transmissible, and Fauci said his colleagues in Britain are seeing a "blip" in cases, though "their intensive care bed usage is not going up, which means they're not seeing a blip up of severe disease." The U.S. pandemic trajectory has lagged behind Britain's for about three weeks.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
'Raising children yourself doesn't end up making a ton of economic sense'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
8 new cookbooks for a delicious fall
The Week Recommends With a big ole emphasis on baking. Because it is the season.
By Scott Hocker, The Week US Published
-
Rudy Giuliani stripped of DC law license
Speed Read The former Republican mayor was disbarred over his efforts to subvert the 2020 presidential election
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published